MX2010010213A - Peptido parcial de lacritina. - Google Patents
Peptido parcial de lacritina.Info
- Publication number
- MX2010010213A MX2010010213A MX2010010213A MX2010010213A MX2010010213A MX 2010010213 A MX2010010213 A MX 2010010213A MX 2010010213 A MX2010010213 A MX 2010010213A MX 2010010213 A MX2010010213 A MX 2010010213A MX 2010010213 A MX2010010213 A MX 2010010213A
- Authority
- MX
- Mexico
- Prior art keywords
- lacritin
- polypeptide
- promote
- cell
- partial sequence
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102100034719 Extracellular glycoprotein lacritin Human genes 0.000 title abstract 4
- 101001090521 Homo sapiens Extracellular glycoprotein lacritin Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 210000004027 cell Anatomy 0.000 abstract 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract 2
- 210000002744 extracellular matrix Anatomy 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención tiene el objetivo de proporcionar un polipéptido que tiene una secuencia parcial de lacritina, que es capaz de promover la adhesión entre una célula y una matriz extracelular; y un polipéptido que tiene una secuencia parcial de lacritina, que tiene una acción de promover la secreción de fluido lagrimal; la presente invención proporciona un polipéptido que comprende la secuencia de aminoácidos de SEQ ID NO: 1, que es una secuencia parcial particular de lacritina, y que tiene una longitud de aminoácidos de no más de 70 residuos; el polipéptido de la presente invención puede promover la adhesión entre una célula y una matriz extracelular; el polipéptido de la presente invención puede promover la secreción de fluido lagrimal desde células acinares de la glándula lagrimal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008071065 | 2008-03-19 | ||
| PCT/JP2009/055489 WO2009116639A1 (ja) | 2008-03-19 | 2009-03-19 | ラクリチンの部分ペプチド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010010213A true MX2010010213A (es) | 2010-10-05 |
Family
ID=41091037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010010213A MX2010010213A (es) | 2008-03-19 | 2009-03-19 | Peptido parcial de lacritina. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8383130B2 (es) |
| EP (1) | EP2270141B9 (es) |
| JP (1) | JP5475640B2 (es) |
| KR (1) | KR20100137510A (es) |
| CN (1) | CN102083974A (es) |
| BR (1) | BRPI0910923A2 (es) |
| CA (1) | CA2718706A1 (es) |
| MX (1) | MX2010010213A (es) |
| RU (1) | RU2010142486A (es) |
| WO (1) | WO2009116639A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518412B2 (en) | 2009-09-16 | 2013-08-27 | Senju Pharmaceutical Co, Ltd. | Partial peptide of lacritin |
| WO2011037196A1 (ja) * | 2009-09-25 | 2011-03-31 | 千寿製薬株式会社 | ラクリチン遺伝子の転写調節因子のスクリーニング方法 |
| GB201304829D0 (en) * | 2013-03-15 | 2013-05-01 | Petrowell Ltd | Method and apparatus |
| US10676505B2 (en) | 2016-06-16 | 2020-06-09 | Sunstar Inc. | Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof |
| WO2018156501A1 (en) * | 2017-02-21 | 2018-08-30 | Tearsolutions, Inc. | Stable peptide compositions |
| KR102337935B1 (ko) * | 2019-04-18 | 2021-12-10 | 코스맥스 주식회사 | 라크리틴을 포함하는 피부장벽 개선 및 보습 증진용 화장료 조성물 |
| CN117143256B (zh) * | 2023-10-27 | 2024-01-26 | 英特菲尔(成都)生物制品有限责任公司 | 一种用于毛发修护的细胞外基质蛋白及其制备方法与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081984A1 (en) * | 2001-02-20 | 2004-04-29 | Laurie Gordon W. | Ocular tear growth factor-like protein |
| JP4745525B2 (ja) | 2001-05-09 | 2011-08-10 | 実 上田 | 角膜治療用培養上皮細胞シート及びその製造方法 |
| ES2372814T3 (es) | 2001-11-19 | 2012-01-26 | Arblast Co., Ltd. | Lámina semejante a la ectocórnea y método para construir la misma. |
| JP3935096B2 (ja) | 2003-02-14 | 2007-06-20 | 株式会社セルシード | 高生着性角膜上皮代替細胞シート、製造方法及びその利用方法 |
| JP2004298447A (ja) | 2003-03-31 | 2004-10-28 | Menicon Co Ltd | 結膜上皮細胞からなる角膜ないし結膜治療用培養シート、およびその作製方法 |
| WO2005119899A2 (en) | 2004-05-13 | 2005-12-15 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
| JP2008071065A (ja) | 2006-09-13 | 2008-03-27 | Hitachi Ltd | インライン展開を行うコンパイル装置、方法、プログラム、記憶媒体 |
| US20090312252A1 (en) * | 2006-09-14 | 2009-12-17 | University Of Virginia Patent Foundation | Antimicrobial Activity in Variants of Lacritin |
-
2009
- 2009-03-19 CA CA2718706A patent/CA2718706A1/en not_active Abandoned
- 2009-03-19 MX MX2010010213A patent/MX2010010213A/es active IP Right Grant
- 2009-03-19 EP EP09722944.7A patent/EP2270141B9/en not_active Not-in-force
- 2009-03-19 WO PCT/JP2009/055489 patent/WO2009116639A1/ja not_active Ceased
- 2009-03-19 CN CN2009801094681A patent/CN102083974A/zh active Pending
- 2009-03-19 BR BRPI0910923-4A patent/BRPI0910923A2/pt not_active IP Right Cessation
- 2009-03-19 KR KR1020107022979A patent/KR20100137510A/ko not_active Withdrawn
- 2009-03-19 RU RU2010142486/10A patent/RU2010142486A/ru not_active Application Discontinuation
- 2009-03-19 US US12/922,084 patent/US8383130B2/en not_active Expired - Fee Related
- 2009-03-19 JP JP2010503936A patent/JP5475640B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009116639A1 (ja) | 2009-09-24 |
| JP5475640B2 (ja) | 2014-04-16 |
| KR20100137510A (ko) | 2010-12-30 |
| BRPI0910923A2 (pt) | 2018-12-26 |
| EP2270141B9 (en) | 2015-12-16 |
| CN102083974A (zh) | 2011-06-01 |
| JPWO2009116639A1 (ja) | 2011-07-21 |
| US20110008891A1 (en) | 2011-01-13 |
| CA2718706A1 (en) | 2009-09-24 |
| EP2270141B1 (en) | 2015-05-27 |
| US8383130B2 (en) | 2013-02-26 |
| EP2270141A4 (en) | 2011-08-24 |
| EP2270141A1 (en) | 2011-01-05 |
| RU2010142486A (ru) | 2012-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010010213A (es) | Peptido parcial de lacritina. | |
| UA103216C2 (uk) | Поліпептид з ксиланазною активністю | |
| UA103215C2 (uk) | Поліпептид з ксиланазною активністю | |
| NZ600731A (en) | Oxyntomodulin peptide analogue | |
| NZ595495A (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them | |
| NZ600732A (en) | Oxyntomodulin peptide analogue | |
| NZ624533A (en) | Novel immunotherapy against several tumors including neuronal and brain tumors | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| IN2014CN02050A (es) | ||
| NZ590050A (en) | Fgf21 mutants and uses thereof | |
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| NZ591612A (en) | Prevention, treatment and diagnosis of p.gingivalis infection with peptides | |
| WO2008105178A1 (ja) | リポソーム用生体成分抵抗性増強剤及びこれにより修飾されたリポソーム | |
| CY1111630T1 (el) | Παραγωγα κυτοκινων | |
| SG10201803541TA (en) | Biologically active c-terminal arginine-containing peptides | |
| NZ589365A (en) | Peptidyl diacylglycerides | |
| NZ601647A (en) | Variant hhip1 protein and methods and uses thereof | |
| NZ591133A (en) | Novel melanoma antigen peptide and uses thereof | |
| WO2013073968A3 (en) | Agents for modulation of cell signalling | |
| NO20081503L (no) | T-celle adhesjonsmolekyl, og antistoff dertil | |
| WO2008109433A8 (en) | Anti-angiogenic peptides | |
| ES2421885T3 (es) | Polipéptidos y procedimiento para la detección específica de anticuerpos en pacientes con una infección por Borrelia | |
| WO2006123157A3 (en) | Nematistatic protein | |
| PT1633859E (pt) | Linha celular e suas utilizações | |
| WO2009054361A1 (ja) | 発毛促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |